Cigna Corp (CI): Today's Featured Health Care Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Cigna ( CI) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.2%. By the end of trading, Cigna rose 61 cents (1.2%) to $52.53 on light volume. Throughout the day, 1.5 million shares of Cigna exchanged hands as compared to its average daily volume of 2.4 million shares. The stock ranged in a price between $51.86-$52.54 after having opened the day at $51.95 as compared to the previous trading day's close of $51.92. Other companies within the Health Care sector that increased today were: BSD Medical Corporation ( BSDM), up 20.8%, Novogen ( NVGN), up 19.2%, Response Genetics ( RGDX), up 17%, and MEI Pharma ( MEIP), up 14.3%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

CIGNA Corporation, a health services organization, through its subsidiaries, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $14.77 billion and is part of the health services industry. The company has a P/E ratio of 9.5, below the S&P 500 P/E ratio of 17.7. Shares are up 23.6% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Cigna a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, increase in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, CombiMatrix Corporation ( CBMX), down 18.3%, NovaBay Pharmaceuticals ( NBY), down 18%, Lifevantage Corporation ( LFVN), down 16%, and Cyclacel Pharmaceuticals ( CYCC), down 14%, were all laggards within the health care sector with Warner Chilcott ( WCRX) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.